SE0021181559 on Nasdaq Stockholm AB

Guard Therapeutics

Logo: guardtherapeutics.com³

Guard Therapeutics is a Swedish clinical-stage biotechnology company based in Stockholm, founded in 2008.¹ Its shares trade on Nasdaq Stockholm AB under the symbol SE0021181559.¹

Price unavailable

Last updated Oct 21, 2026.

Overview

2008Founded¹

Compare with another stock.

TickerSE0021181559 on Nasdaq Stockholm AB¹
Industrybiotechnology, pharmaceutical industry¹
HeadquartersStockholm¹
Websiteguardtherapeutics.com
Legal formaktiebolag¹
Listed onSpotlight Stock Market, Nasdaq Stockholm AB (SE0021181559)¹
LEI549300DTX7T87FGYG180²
StatusActive²
LEI statusIssued and current²
Registered addressBox 5216, 102 45 Stockholm, Sweden²
Registered withSwedish Companies Registration Office, 556755-3226²

See how the biggest companies compare on our leaderboards

Leadership

Who has led Guard Therapeutics, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (1)

Chief medical officerMichael Reusch Jan 1, 2022 to now¹

Timeline

Jun 20, 2017Went public Listed on Nasdaq Stockholm AB¹
2008Founded Founded¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataGuard Therapeutics on Wikidata
2
GLEIFGuard Therapeutics LEI record (549300DTX7T87FGYG180)
3
Company websiteGuard Therapeutics logo

Overview

Leadership

Timeline

Links

Sources